Lilly announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with type 2 diabetes and obesity or overweight. At 80 weeks, all doses of retatrutide (4 mg, 9 mg, and […]
Clinical Insights & Research
Women with Enlarged Breast Tissue More Likely to Experience Chronic Migraine, Neck Pain and Sleep Apnea, Study Finds
Women with enlarged breast tissue, known medically as macromastia, may be more likely to experience chronic migraine, neck pain, certain spinal nerve disorders and obstructive sleep apnea, according to a new study by Wake Forest University School of Medicine researchers, published Tuesday in the journal Headache. The findings suggest enlarged […]
Oral Infigratinib Shows Benefits Beyond Growth in Children with Achondroplasia
BridgeBio Pharma, Inc., presented new exploratory analyses from PROPEL 3, the global Phase 3 pivotal study of oral infigratinib in children living with achondroplasia, showing directionally favorable trends beyond growth across medical complications associated with achondroplasia, including sleep apnea, otitis media, and body composition. These data were presented at the […]
JOMS Study: Jaw Pain Condition May Signal Higher Risk for Sleep Apnea, Research Finds
Patients diagnosed with a temporomandibular disorder (TMD) are at increased risk for obstructive sleep apnea (OSA) compared to people without the disorder, according to a study published in the Journal of Oral and Maxillofacial Surgery (JOMS), the peer-reviewed official journal of the American Association of Oral and Maxillofacial Surgeons (AAOMS). TMD […]
The Lancet Neurology Publishes Positive Alixorexton Vibrance-1 Data in Narcolepsy Type 1
Alkermes plc announced the publication of data from the Vibrance‑1 phase 2 study of alixorexton in adults with narcolepsy type 1 (NT1) in The Lancet Neurology. Alixorexton is a novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development for the treatment of NT1, narcolepsy type 2 (NT2) and […]
Workout or Nap? Either Can Help Your Sleepless Brain
A short workout or a nap can help protect memory after a sleepless night, a McGill University-led study has found. Researchers found people who either completed 20 minutes of moderate-to-vigorous exercise or took a 90-minute nap performed about 22 per cent better on memory tests after 30 hours without sleep […]
Too Little or Too Much Sleep Associated With Faster Biological Aging
An analysis of biological clocks throughout the human body suggests that too few hours of sleep—and too many—may speed aging in the brain, heart, lung, and immune system and is associated with a wide range of diseases. “Previous studies have found that sleep is largely linked to aging and the […]
High-Dose Vitamin D Linked to Better Cognitive Function in Adults at Risk of Dementia
With more than 7 million Americans living with Alzheimer’s dementia — a number projected to reach nearly 13 million by 2050 — new Emory University research suggests that higher vitamin D supplement intake may be associated with better cognitive function in adults with an elevated risk of dementia. In a […]
AI Identifies Previously Unrecognized Health Insights in Routine Sleep Studies
A novel AI model can use information collected during routine sleep studies to identify patients’ long-term health risks, according to a new study published in Nature Communications. Developed by a multidisciplinary research team, the model uncovered hidden sleep patterns linked to risks including heart disease, cognitive decline and death. The […]
New Study Uses Sleep Monitoring and AI to Detect Alzheimer’s
Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer’s. The […]


















